Epidemiology and Laboratory Capacity (ELC) HAI/AR Program Funded Activities (August 2020 – July 2021)
Many of these activities complement CDC AR investments, collectively known as CDC’s AR Solutions Initiative, to fight antibiotic resistance across healthcare, community, and food in all 50 states, six large cities, Puerto Rico, US Virgin Islands, and six US-affiliated pacific islands.
- Rapid Response, Containment, and Prevention Capacity– Coordination and implementation of HAI/AR prevention activities across the state/city/territory, managing the program’s advisory group, and implementing and reporting on progress of the HAI/AR plan. Activities focus on promoting proven prevention practices, detecting and responding to HAI/AR outbreaks, and increasing the use of National Healthcare Safety Network (NHSN) to track and prevent HAIs and transmission of AR pathogens in healthcare settings.
- Expanded Infection Prevention and Control (IPC) Capacity – With significant additional funding provided via the CARES and Enhancing Detection ELC supplements as part of the COVID-19 pandemic response, recipients will increase capacity to identify infections and IPC breaches, conduct IPC assessments, and mitigate IPC gaps in healthcare settings across the provider spectrum.
- Rapid Detection of AR Pathogens through Enhanced State HAI/AR Laboratory Capacity, Coordination and Outreach – As part of AR Lab Network activities, all state public health laboratories and four major cities/territories receive support and lab capacity to detect, confirm, and characterize AR pathogens and novel resistance mechanisms. This will improve response to outbreaks and containment of AR threats in healthcare such as CRE, carbapenem-resistant Pseudomonas aeruginosa (CRPA), and C. auris.
- Educational Efforts to Promote Appropriate Antibiotic Use – Assists state and local-level agencies in implementing health communication programs and behavioral interventions to promote appropriate antibiotic use. These programs aim to improve the knowledge, attitudes and behaviors of the general public and health care providers, contributing to a reduction in inappropriate prescribing and antibiotic resistance.
- Coordinated Prevention and Stewardship – Support for state and local health departments to improve tracking of antibiotic use and resistance and expanding coordinated prevention and stewardship activities across the spectrum of healthcare.
- External Data Validation – Build and sustain health department programs’ ability to ensure the quality of healthcare-associated infection data reported to the National Healthcare Safety Network (NHSN).
- Antibiotic Resistance Laboratory Network (AR Lab Network) – Support the AR Lab Network to track changes in resistance and help identify and respond to outbreaks faster. The AR Lab Network includes labs in 50 states, several cities, and Puerto Rico, including seven regional labs and the National Tuberculosis Molecular Surveillance Center (National TB Center). It supports nationwide lab capacity to rapidly detect antibiotic resistance in healthcare, food, and the community, and inform local responses to prevent spread and protect people. The AR Lab Network is capable of detecting known and emerging resistance threats, such as increased testing nationwide for the fungal threat Candida, including the emerging drug-resistant C. auris. The AR Lab Network also identifies germs that could be used to support researchers in developing new diagnostics and more treatment options through the CDC AR Isolate Bank. Learn more about the AR Lab Network and AR investments in your state.
- Project Firstline IPC Training – Supported by COVID-19 resources and as part of CDC’s Project Firstline Collaborative, recipients will assist in providing innovative IPC training to front-line healthcare personnel while also creating IPC training expertise in the public health workforce. Recipients will help build a foundation of IPC knowledge and a culture of IPC expertise in the healthcare and public health communities, in order to keep healthcare workers, patients, and the healthcare environment safe from COVID-19 and other infectious disease threats.